Skip to main content
Clinical Trials/NCT03076853
NCT03076853CompletedNot Applicable

Medication Assessment Through Real Time Information eXchange - Distributed Pharmaceutical Record System

Centre Hospitalier Universitaire de Nice1 site in 1 country511 target enrollmentStarted: April 3, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
511
Locations
1
Primary Endpoint
Modification of the medical prescription linked to the use of the pharmaceutical record

Study Overview

Brief Summary

The aim of MATRIX-DPRS is to assess the clinical and organizational impacts of the use of the medication record, opened, filled and managed by pharmacists (from private office and hospital units) by hospital physicians in private and public healthcare establishments (volunteers), for three clinical contexts: anaesthesiology visit before surgery, medications abuse and emergency hospitalization, medications and elderly hospitalisations.

Detailed Description

As part of the national 2012 PREPS call for proposals, a multidisciplinary research team was set up to design and develop methods in order to evaluate the efficiency and the performance of health data information systems. This team is composed of physicians and researchers in medical informatics, hospital information systems, biostatistics, process analysis and management in healthcare, ergonomics and usability. This study was aimed to evaluate the clinical and organizational impacts of the use of a new source of information brought by the pharmaceutical record, promoted by the national committee of pharmacists. This record is opened and filled for each patient by the pharmacist. It contains all the medication sold (prescribed by physician and OTC) by the patient. This record is used by almost all the private pharmacists. The French Health Ministry was looking for an evaluation of this new source of information by hospital physicians in order to be applied by any healthcare institution or organization wishing to evaluate the added value of its investments or recommendations (example: ARS (French Regional Health Agency), DGOS (French Directorate General of Health Services), etc.) in the information system.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Concerning Anesthesia department:
  • Patients in pre-anesthesia consultation for scheduled intervention.
  • Concerning Emergencies department:
  • Patients admitted for fainting fit
  • Regarding patients hospitalized in geriatrics:
  • Patients admitted to geriatrics

Exclusion Criteria

  • Patients without administrative or judicial freedom if the authorization of the legal representative can not be collected.

Outcomes

Primary Outcomes

Modification of the medical prescription linked to the use of the pharmaceutical record

Time Frame: 3 months

The primary outcome measure is to evaluate the impact of the use of the pharmaceutical record on th medical prescription. The doctor writes a first medical prescription without using the pharmaceutical record and a second with the pharmaceutical record.The changes are analyzed.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Medication Assessment Through Real Time... | Clinical Trial